Health Grants Government Bids & Contracts

Active government bids and RFPs matched to this category. Sorted by due date.

Browse by Industry Browse by State 🌐 See these bids on the map

Government Bids Results: 1 - 25 of 133 Federal only ✕ clear

Show: 25 100 500 All per page

Coverage: 🇺🇸 United States 🇨🇦 Canada 🇲🇽 Mexico 🇪🇺 European Union 🇬🇧 United Kingdom 🇦🇺 Australia 🇮🇳 India 🇿🇦 South Africa 🇰🇪 Kenya 🇺🇬 Uganda

Filter by Status: Active Open Early Lead Upcoming ✓ Federal Federal bid

Request	Due Date	State	Status
GREGoRi Innovation Projects (U01 Clinical Trial Optional)	Oct 30, 2026	District of Columbia	Federal
Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18)	Oct 30, 2026	District of Columbia	Federal
Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01)	Oct 30, 2026	District of Columbia	Federal
Large Health Services Research Demonstration and Dissemination Projects for Prevention of Healthcare-Associated Infections (R18)	Oct 30, 2026	District of Columbia	Federal
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)	Oct 30, 2026	District of Columbia	Federal
Large Research Projects for Prevention of Healthcare-Associated Infections (R01)	Oct 30, 2026	District of Columbia	Federal
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)	Oct 30, 2026	District of Columbia	Federal
AHRQ Conference Grant Programs (R13)	Oct 31, 2026	District of Columbia	Federal
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)	Nov 2, 2026	District of Columbia	Federal
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)	Nov 2, 2026	District of Columbia	Federal
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)	Nov 10, 2026	District of Columbia	Federal
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)	Nov 10, 2026	District of Columbia	Federal
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)	Nov 10, 2026	District of Columbia	Federal
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)	Nov 13, 2026	District of Columbia	Federal
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)	Nov 13, 2026	District of Columbia	Federal
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)	Nov 13, 2026	District of Columbia	Federal
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)	Nov 17, 2026	District of Columbia	Federal
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)	Nov 17, 2026	District of Columbia	Federal
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)	Nov 17, 2026	District of Columbia	Federal
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)	Nov 19, 2026	District of Columbia	Federal
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel Therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)	Nov 19, 2026	District of Columbia	Federal
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)	Nov 23, 2026	District of Columbia	Federal
National Center for Construction Safety and Health Research and Translation (U54)	Dec 1, 2026	District of Columbia	Federal
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)	Dec 2, 2026	District of Columbia	Federal
Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)	Dec 4, 2026	District of Columbia	Federal